TRTânia Carlice dos Reis

Tânia Carlice dos Reis

*This is an algorithmically generated author record based on publicly available information.

Tânia Carlice dos Reis has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perspectivas sobre o enfrentamento da pandemia de Covid-19 em Cabo verde e no Brasil e o impacto das políticas públicas emergenciais

    by Hilton Pereira da Silva, Tânia Carlice dos Reis, Keily Silva

    Em janeiro de 2020 a Organização Mundial de Saúde (OMS) identificou uma emergência epidemiológica internacional em decorrência do SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Este artigo apresenta alguns dados disponibilizados em plataformas públicas oficiais sobre a situação da COVID-19, analisa o processo de enfrentamento pelos governos centrais em Cabo Verde e no Brasil e discute como as políticas sociais e de saúde executadas por cada país repercutiram no impacto epidemiológico ao longo do primeiro ano da pandemia, buscando exemplificar como a tomada de decisão sobre a condução das políticas públicas influencia a morbidade e mortalidade nos dois países. Apesar das limitações analíticas em face a uma crise global ainda em andamento, esperamos que este trabalho contribua para ampliar as pesquisas comparativas entre países lusófonos do Cone Sul e para demonstrar a importância da gestão política para o enfrentamento desta doença e das que possam emergir futuramente.


  • Open Access

    Investigation of mutations in the HBB gene using the 1,000 genomes database

    by Tânia Carlice-Dos-Reis, Jaime Viana, Fabiano Cordeiro Moreira, Greice De Lemos Cardoso, João Guerreiro, Sidney Santos, Ândrea Ribeiro-Dos-Santos

    Mutations in the HBB gene are responsible for several serious hemoglobinopathies, such as sickle cell anemia and β-thalassemia. Sickle cell anemia is one of the most common monogenic diseases worldwide. Due to its prevalence, diverse strategies have been developed for a better understanding of its molecular mechanisms. In silico analysis has been increasingly used to investigate the genotype-phenotype relationship of many diseases, and the sequences of healthy individuals deposited in the 1,000 Genomes database appear to be an excellent tool for such analysis. The objective of this study is to analyze the variations in the HBB gene in the 1,000 Genomes database, to describe the mutation frequencies in the different population groups, and to investigate the pattern of pathogenicity. The computational tool SNPEFF was used to align the data from 2,504 samples of the 1,000 Genomes database with the HG19 genome reference. The pathogenicity of each amino acid change was investigated using the databases CLINVAR, dbSNP and HbVar and five different predictors. Twenty different mutations were found in 209 healthy individuals. The African group had the highest number of individuals with mutations, and the European group had the lowest number. Thus, it is concluded that approximately 8.3% of phenotypically healthy individuals from the 1,000 Genomes database have some mutation in the HBB gene. The frequency of mutated genes was estimated at 0.042, so that the expected frequency of being homozygous or compound heterozygous for these variants in the next generation is approximately 0.002. In total, 193 subjects had a non-synonymous mutation, which 186 (7.4%) have a deleterious mutation. Considering that the 1,000 Genomes database is representative of the world’s population, it can be estimated that fourteen out of every 10,000 individuals in the world will have a hemoglobinopathy in the next generation.